Karius, Inc.

Karius, Inc.

Karius, Inc.

Karius is focused on conquering infectious diseases. 1250+ pathogens detected from a single blood draw using NGS. CLIA-licensed and CAP Accredited.
Type
B2b
Founded
2014
Raised
$240M
Follow us
Alexa global traffic share
Twitter followers
Team Size
50+
Employees
neurons.AI

Karius Named to Forbes AI 50 List of Most Promising Artificial Intelligence Companies

Fast Company , Pulse 2.0

This tech quickly searches your blood for more than 1,400 pathogens

$165,000,000 Venture capital (Series B)
FinSMEs , VentureBeat

Karius Raises $165M In Series B Funding

TechCrunch

Karius raises $165 million for its liquid biopsy technology identifying diseases with a blood draw

$25,000,000 Debt financing
FinSMEs

Karius Receives $25M Senior Secured Facility

$50,000,000 Venture capital (Series A)
GenomeWeb , PE HUB , Medium , +2

Karius Raises $50M in Series A Financing